These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25539800)

  • 61. Treatment of recurrent urosepsis with tigecycline: a pharmacological perspective.
    Curcio D
    J Clin Microbiol; 2008 May; 46(5):1892-3. PubMed ID: 18460636
    [No Abstract]   [Full Text] [Related]  

  • 62. Efficacy and safety of tigecycline: a systematic review and meta-analysis.
    Yahav D; Lador A; Paul M; Leibovici L
    J Antimicrob Chemother; 2011 Sep; 66(9):1963-71. PubMed ID: 21685488
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Acute pancreatitis related to tigecycline: case report and review of the literature.
    Gilson M; Moachon L; Jeanne L; Dumaine V; Eyrolle L; Morand P; Ben m'Rad M; Salmon D
    Scand J Infect Dis; 2008; 40(8):681-3. PubMed ID: 18979610
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tigecycline: an antibiotic for the twenty-first century.
    Dryden M
    J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii3-4. PubMed ID: 23772044
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of tigecycline.
    Falagas ME; Karageorgopoulos DE; Dimopoulos G
    Curr Drug Metab; 2009 Jan; 10(1):13-21. PubMed ID: 19149509
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Tigecycline: 10 years of history and still in full force].
    Barberán J; Salso S; Alhambra A
    Rev Esp Quimioter; 2015 Apr; 28(2):61-78. PubMed ID: 25904513
    [No Abstract]   [Full Text] [Related]  

  • 67. The emergence of clinical resistance to tigecycline.
    Sun Y; Cai Y; Liu X; Bai N; Liang B; Wang R
    Int J Antimicrob Agents; 2013 Feb; 41(2):110-6. PubMed ID: 23127485
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tigecycline use in serious nosocomial infections: a drug use evaluation.
    Bassetti M; Nicolini L; Repetto E; Righi E; Del Bono V; Viscoli C
    BMC Infect Dis; 2010 Sep; 10():287. PubMed ID: 20920273
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
    Florescu I; Beuran M; Dimov R; Razbadauskas A; Bochan M; Fichev G; Dukart G; Babinchak T; Cooper CA; Ellis-Grosse EJ; Dartois N; Gandjini H;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i17-28. PubMed ID: 18684703
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin.
    Bergallo C; Jasovich A; Teglia O; Oliva ME; Lentnek A; de Wouters L; Zlocowski JC; Dukart G; Cooper A; Mallick R;
    Diagn Microbiol Infect Dis; 2009 Jan; 63(1):52-61. PubMed ID: 18990531
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antimicrobial activity of tigecycline against bacterial isolates from intensive care units in a teaching hospital in Central Saudi Arabia.
    Somily AM; Al-Khattaf AS; Kambal AM
    Saudi Med J; 2010 Jan; 31(1):18-24. PubMed ID: 20062893
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Acute pancreatitis in ICU secondary to treatment with tigecycline.
    Bernas Albeniz A; Aveiga Valencia DA; Etxeberria Zabala L; Zaldibar-Gerrikagoitia Bilbao J; Aguilera Celorrio L
    Rev Esp Anestesiol Reanim; 2017 Jan; 64(1):46-49. PubMed ID: 27609674
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tigecycline: a review of properties, applications, and analytical methods.
    da Silva LM; Nunes Salgado HR
    Ther Drug Monit; 2010 Jun; 32(3):282-8. PubMed ID: 20431506
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical pharmacokinetics and pharmacodynamics of tigecycline.
    Barbour A; Schmidt S; Ma B; Schiefelbein L; Rand KH; Burkhardt O; Derendorf H
    Clin Pharmacokinet; 2009; 48(9):575-84. PubMed ID: 19725592
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Evaluation of the efficacy and safety of tigecycline for treatment of respiratory tract infections: systematic review of literature].
    Moya Cordero P; Ruiz-Aragón J; Molina Linde JM; Márquez-Peláez S; Motiva Sánchez V
    Rev Chilena Infectol; 2013 Dec; 30(6):591-7. PubMed ID: 24522299
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Tigecycline: an expanded broad-spectrum intravenous antibiotic. Preface and summary.
    Felmingham D
    J Chemother; 2005 Aug; 17 Suppl 1():3-4. PubMed ID: 16429623
    [No Abstract]   [Full Text] [Related]  

  • 77. An essential requirement for the licensing of new antibiotics is the provision of data on efficacy and safety obtained from clinical trials in which patients are randomized to receive either the experimental drug or a comparator antibiotic regarded as a standard treatment option. Preface.
    Johnson AP; Leibovici L
    J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii1. PubMed ID: 23930279
    [No Abstract]   [Full Text] [Related]  

  • 78. Tigecycline-induced acute pancreatitis: about two cases and review of the literature.
    Marot JC; Jonckheere S; Munyentwali H; Belkhir L; Vandercam B; Yombi JC
    Acta Clin Belg; 2012; 67(3):229-32. PubMed ID: 22897076
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Efficacy and safety of tigecycline for the treatment of severe infectious diseases: an updated meta-analysis of RCTs.
    Shen F; Han Q; Xie D; Fang M; Zeng H; Deng Y
    Int J Infect Dis; 2015 Oct; 39():25-33. PubMed ID: 26283551
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Tigecycline--a new antibiotic].
    Skibeli V; Aaløkken I; Lingaas E; Midtvedt T; Solberg CO; Melby KK
    Tidsskr Nor Laegeforen; 2010 Aug; 130(16):1624-6. PubMed ID: 20805861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.